141 related articles for article (PubMed ID: 25915869)
1. Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis.
Fan Y; Wei F; Lang Y; Wang S
J Hypertens; 2015 Apr; 33(4):681-8; discussion 689. PubMed ID: 25915869
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors.
Goldberg AI; Dunlay MC; Sweet CS
J Hypertens Suppl; 1995 Jul; 13(1):S77-80. PubMed ID: 18800461
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.
Xi GL; Cheng JW; Lu GC
Am J Hypertens; 2008 May; 21(5):546-52. PubMed ID: 18437146
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
5. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
6. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
Wu SC; Liu CP; Chiang HT; Lin SL
Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension.
Zhenfeng Zheng ; Huilan Shi ; Junya Jia ; Dong Li ; Shan Lin
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):365-74. PubMed ID: 21421652
[TBL] [Abstract][Full Text] [Related]
8. Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population.
Dang A; Zhang Y; Liu G; Chen G; Song W; Wang B
J Hum Hypertens; 2006 Jan; 20(1):45-50. PubMed ID: 16281062
[TBL] [Abstract][Full Text] [Related]
9. Losartan vs. amlodipine treatment in elderly oncologic hypertensive patients: a randomized clinical trial.
Motta M; Russo C; Vacante M; Liardo RL; Reitano F; Cammalleri L; Costanzo M; Benfatto G; Frazzetto P; Mondati E; Malaguarnera M; Pennisi G
Arch Gerontol Geriatr; 2011; 53(1):60-3. PubMed ID: 20569998
[TBL] [Abstract][Full Text] [Related]
10. Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors.
Paster RZ; Snavely DB; Sweet AR; Draper RA; Goldberg AI; Soffer BA; Sweet CS
Clin Ther; 1998; 20(5):978-89. PubMed ID: 9829449
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
12. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
13. Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension.
Díez J
Clin Ther; 2006 Jun; 28(6):832-48. PubMed ID: 16860167
[TBL] [Abstract][Full Text] [Related]
14. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
He YM; Feng L; Huo DM; Yang ZH; Liao YH
Nephrology (Carlton); 2013 Sep; 18(9):605-14. PubMed ID: 23869492
[TBL] [Abstract][Full Text] [Related]
15. [The effects of angiotensin II receptor blockers in hypertensive patients complicating hyperuricaemia].
Dang AM; Liu GZ; Zhang YH; Chen GL;
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):882-5. PubMed ID: 17217711
[TBL] [Abstract][Full Text] [Related]
16. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
Smith DH; Dubiel R; Jones M
Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
19. Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients.
Hamada T; Mizuta E; Kondo T; Hirai M; Yamada K; Kato M; Shigemasa C; Yamamoto Y; Ninomiya H; Igawa O; Hisatome I
Arzneimittelforschung; 2010; 60(2):71-5. PubMed ID: 20329654
[TBL] [Abstract][Full Text] [Related]
20. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
